15q11.2...............T167

1H MRS...............T128, W113, W177

1NMPP1...............W160

22q11...............32, W32

31P Magnetic Resonance Spectroscopy...............W188

5-HT2A receptor...............W166

5F-PB-22...............T250

6-OHDA...............W138

7-Tesla...............W101

7q11.23...............W28

[11C]DPA-713...............T140

A

Abuse Potential...............4, T208, T249

accelerometry, mood disorders, big data...............W105

acetylcholine...............M4, M130, W64

acoustic startle...............M171, T78, W17

Actigraphy...............M114, W105

Acute Stress...............M104, T247, T253, W97

Adaptive Behavior...............T136

addiction...............5, M222, M223, M224, M228, M233, M257, 14, 19, T51, T53, T171, T210, T212, T215, T216, T219, T242, T249, 28, 43, W126, W217, W242, W261, 51, 55

adenosine...............31

ADHD...............T31, W26, W29, W34

adherence...............M153

adjunctive treatment...............T82

Adjuvant thiamine...............M81

Adolescence...............M24, M27, M28, M162, M257, T26, 31 T94, T171, T210, T244, T260, W31

Adolescent...............M26, M67

Adolescent Alcohol...............W237

Adolescent binge drinking...............44

Adolescent Depression...............M30, T35, T102, W38

Adolescent Development...............T21

Adolescent Stress...............M33, T21

Adolescents...............T39, W37, W40

adult neurogenesis...............M99, T241

advantages of the combination of therapies...............T134

affective disorders...............M130

African American...............W109

aggression...............T52, T149, W51

Aging...............M4, M146, M147, M151, T3, T4, T113, W2, W233

aging and dementia...............W3

Agitation...............M187

AKT1/AKT3...............W151

Alcohol...............M28, M215, M222, M247, T211, T224, T261, W221, W235, W239

alcohol and drugs...............60

Alcohol consumption...............T42, W258

Alcohol dependence...............M227, M241, M253, M259, T231, W209, W245, W255

alcohol self-administration...............M245, M256, W255

Alcohol Sensitivity...............T262

alcohol use disorder...............M219, T211, T220, T222, W253

Alcohol withdrawal syndrome...............W220

Alcohol-preferring rats...............W220, W236

Alcohol-seeking...............W236

Alcohol-seeking behavior...............T238, W142

Alcoholism...............M251, M256, M263, 11, 52

alic...............W136

all is in the timing...............T134

allopregnanolone...............T78

alpha 5...............T212, W238

alpha-7 nicotinic acetylcholine receptor...............M25, T206, T207

Altitude...............T97, T236

Alzheimer's Disease...............M41, M43, 16, M145, T2, T43, T44, T141, W1, W4, W41, W42, W43

Ambiguity...............T217

Amino acid mixture...............T72

Amish...............25

AMPA...............W95

AMPA antagonist...............M142

AMPA glutamate receptors...............W221

AMPA receptor...............M77, M186

Amphetamine...............M180, M260

amplitude of low frequency fluctuation...............M163

Amygdala...............M6, M14, M78, M97, M131, M211, T14, T16, T28, T35, T90, T172, W25, W144, W237

amygdala-based networks...............T26

Amyloid...............T2

Amyloid Precursor Protein...............W41

anatomical connectivity...............W134

anesthesia...............M121

Anesthetic...............T54, W137

Anger...............M107

anhedonia...............T254, W37, W106, W108, W232

Animal Model...............9, M57, T8, T85, T160, T181, T190

Animal Models...............M76, M157, M263, 18, T65, T70, T91, W79, W146

ankyrin-3...............M99

anorexia nervosa...............M49, T47, W47, W48

anterior cingulate cortex...............T2, T101, T130, W51, W60, W84, W122, W163

anterior prefrontal cortex...............T192

anti-ADHD like action...............W35

Antidepressant...............4, M35, M62, M77, M83, M167, T35, T91, T102, T109, T112, W66, W78, W87, W113, W114

antidepressant response...............M85, T85

Antidepressants...............M59, T56, T58, T61, T81, T101, W70, W97, W111

Antipsychotic...............M157, M159, M167, T201, W39, W168, W174

Antipsychotic agents...............T150

Antipsychotic induced weight gain...............M177, W39

antipsychotic medication...............W206

Antipsychotic monotherapy...............M206

Antipsychotic switching...............M193

Antipsychotic Treatment...............M168, M170, M190, M191, W184

antipsychotic-naive...............W152

Antipsychotic-naïve first-episode schizophrenia...............M190, 12

Antipsychotics...............T157, T174, T181, W132, W156

antisocial personality disorder...............M148, M150

Anxiety...............M15, M31, M88, T13, T14, T17, T59, T63, T67, T120, T148, W6, W8, W10, W15, W20, W81, W87, W94, W126, W144, W237, 52, 55

Anxiety disorders...............M9, M12, M20, T16, 30, 41, W16, W22, 6

anxiety state...............T9

anxiolytic...............W87

Anxious distress...............M88

apathy...............W73

Appetite...............T121

Appetitive Hormones...............5, T137

Arc...............W250

Arcuate...............M126

aripiprazole once-monthly 400 mg (AOM 400)...............T187, W154

ASD...............M8

aspirin...............T76

associative learning...............M213, W251

associative-striatum...............W177

ASSR...............M160, W186

astrocytes...............M133

astroglia...............54

at-risk...............M199, T15, W17

Attention...............M136, M162, M226, T7, T111, T129, T130, T255, W117

Attention Deficit Hyperactivity Disorder...............T53

attentional bias...............M98, T59

attentional bias modification...............W229

atypical antipsychotic drug...............M56, T62, W172

Atypical antipsychotics...............M34, M55, M65, M186, T79, T114, T185, W56

Auditory cortex...............M197

Auditory hallucinations...............T166, W202

augmentation...............M65

Autism...............T25, M38, T34, T132, T142, W27

Autism & depression...............57

Autism spectrum disorder...............M128, M241, W43, W91, W166

autism Spectrum Disorders...............M37, M44, M36, T33, T37, T144, W30, W204

B

Balb/c mouse...............M36

Basal Ganglia...............M232, T105

basolateral amygdala...............M119, M255

bath salts...............M250

BB-22...............T250

BDNF...............M62, M67, M111, M202, T74, T95, T188

Behavior...............M242, 37, 55

behavioral despair...............T68

behavioral economics...............T242

behavioral inhibition...............T53, W25, W142

Behavioral Pharmacology...............M231, T218, T237, W41, W50

behavioral variability...............W26

Behaviors...............M140

benign neutropenia...............M172

benzodiazepine...............M167, W114

beta arrestin...............M165, M169, M261, 53

beta-amyloid peptide 1-42...............T42

big data...............T96

binge drinking...............M263, T211, T218

binge-eating...............T46, W49

Binge-eating disorder...............W46, M47, M48, M223

Bioenergetics...............M199

Bioinformatics...............T144

Biomarker...............M41, M58, M111, T27, T76, T95, T141, W66, W100, W159

Biomarker risk assignment algorithm...............M108

biomarkers...............T8

bipolar...............M199

bipolar depression...............T77

Bipolar Disorder...............M55, M67, M82, M91, M93, M101, M110, M112, M114, M115, M147, M153, M188, T64, T163, T71, T76, T96, T104, T108, T111, T119, T194, W63, W71, W77, W79, W82, W88, W89, W99, W202

Bipolar I Depression...............T62, W56

BNST...............M14, T120

Body Dysmorphic Disorder...............M21

BOLD imaging...............M236, T12

Borderline Personality Disorder...............M149, T146, W147, W148, 47

Brain...............T56, T136

brain activation...............38

Brain Anatomy...............T130

Brain Based Markers for Depression...............M90, M98

brain connectivity...............M1, T32

Brain development...............M35, M50, T41, W25, W181

brain hemispheres...............T134

brain imaging...............30, 52

Brain Stimulation...............T77, 43, W102, W103, W112, W121

brain structure...............W124, W141, W181, W219

brain volume...............T74

brain volumes...............T200, W21

Brain waste removal...............16

Brain-Derived Neurotrophic Factor...............M174

breast cancer...............M139

Brexpiprazole...............M88, M107, M187, M193, T88

bulimia nervosa...............M50

Buprenorphine...............T228, T232, W72

buprenorphine maintenance...............M258

bupropion...............T80

C

c-Fos...............M99, M212

CACNA1C...............T3, T119

caffeine...............M250, T248, 31, W208

calcium...............T119

calcium imaging...............M213, T16, W131, W211, 55

Cannabidiol...............W225, W259

cannabinoids...............M217, M221, T250, 28

cannabis...............M15, 19, T210, T234

Cannabis Dependence...............M154, M247, M262, T168, T256, W227, W241, W260

cannabis use...............T171, T173, T175, T260, W216

CANTAB...............M41

Cardiac Reactivity...............T262

Cardiometabolic Risk...............W39, W132, W190

Career Development...............M124

cariprazine...............M156, M204, M206, T170

catenin cadherin-associated protein, alpha 2,...............M53

CB1 receptor...............T250, W227

CBT...............M18, T22

CCK-4...............M16

Central autonomic network...............M80, W121

Central nucleus of the amygdala...............W59, W221

Cerebral Blood Flow...............M49, W235

Child abuse and neglect...............T39, W233

child offspring...............T104

childhood maltreatment...............M39

Childhood Onset Bipolar Disorder...............23

Childhood trauma...............M26, M210, W145

childhood urban-rural upbring...............W207

Children and Adolescents...............T27, T98, W39

choice...............M216, T252

choline...............M25, T157, T206

cholinergic system...............W43, W64

chromatin...............W27, W139

chronic...............T190

chronic mild stress...............T73, W72

chronic pain...............W86, W143, W230

chronic social defeat...............M96

chronic stress...............M104, T60, T138, W50, W75, W110, W240

cingulate...............T86

circadian...............W239

circadian rhythm...............M12, M111, M139, M147, T258

citalopram...............T80

cladistics...............W158

CLARITY...............W194

Clathrin nanoparticles...............W128

claustrum...............T130, T182

clinical high risk...............T155, T161, T172

Clinical trial...............M83, W129, W169, M86, M128, M241, T195, W43, W91, W166

Clinical Trial Design...............W57

Clinical Trial Methodology...............15, 24

CLOCK...............T258

clomipramine...............W122

clonidine...............M258

Clozapine...............M172, T185, M191, T203, W175, W203

Cluster Analysis...............T204

CNS antibody delivery...............W128

CNS Clinical Trials...............M253, T222

CNV...............T25, W32

co-abuse...............M263, T261

Cocaine...............M213, M214, M220, M222, M231, M233, M243, M250, T183, T216, T219, T229, T233, T235, T253, T261, W210, W217, W228, W242, W243, W250

cocaine addiction...............M223, M225, M236, M237, M239, M240, M248, M252, T251, T252, T254, T258, T259, 28, W35, W212, W214, W219, W222, W246, W247, W254

cocaine seeking...............M211, M255, W222, W231, W240, 54

cocaine-related disorders...............M220

Cognition...............M4, M41, M45, M72, M112, M120, M154, M179, M181, M192, T3, T82, T98, T105, T111, T159, T162, T186, T191, T204, T234, T244, W4, W89, W119, W155, W162, W165, W171

cognitive aging...............M1, M3, T2

cognitive behavior therapy...............M26, M100

cognitive behavioral therapy...............M23, M95

cognitive control...............M90, T117, T173, W23, W51, W226

cognitive control network...............M95

Cognitive Decline...............T87, T113

cognitive deficit...............T196

Cognitive Enhancement...............M28, M130, T24, W125

Cognitive Functioning...............T93

Cognitive impairments...............W188

Cognitive Neuroscience...............M26, 17, T209, 51

cognitive reappraisal...............M149

cognitive remediation...............M166, T152, T164, W205

Cognitive Resilience...............T54, W1

cognitive training...............17

cognitive/emotional task performance...............W116

combat...............T15

combat veteran...............M17, W21

community based family study...............T108

community structure...............T122

compensatory cognitive training...............T151

compulsion...............W9

Compulsive eating...............T49

compulsivity...............M51, M52, M248, 14

computational modeling...............T51, W127

COMT gene...............W145

concerns...............60

conditioned cue...............W7, W142

conditioned place preference...............T229, T236, W211, W249

Conditioned responses...............W120

conflict of interest...............35

Connectivity...............M224, T18, T117, W76, W165, W191

Connectivity strength...............T90

connectome...............T75, W55, W134

connectomics...............T122, W192

consciousness...............T134

Context...............T225, W7

coping...............M23

copy number variation...............M37, 25

cortex...............M137, W130

cortical dynamics...............W192

Cortical Inhibition...............T27, T168, W112

Cortical neurons...............T238

cortical thickness...............W36

cortico-striatal plasticity...............M234

corticoaccumbens circuit...............W49

corticosterone...............M61, T23, W94

Corticotropin-releasing factor (CRF)...............W214

Corticotropin-Releasing Hormone...............M76

Cortisol...............M10, M14, M109, M139, T84, T86

COX-1...............M54

CpG Methylation...............M9

CR845...............M129

craving...............T137, T230, T256

CREB...............T42, T115

CRF...............T233, W5

CRH...............T67, W22, W115

CRHBP...............W14

CRP...............M120, T100

CSF...............M94

CSF Biomarkers...............T87

Cue Reactivity...............W218

cue reinstatement...............M221, M225, W225

Cue-Exposure...............T226, T230

cue-reactivity...............W248

cues...............W212

Cyberball...............T228

cyclic AMP...............W66

CYP2C19...............M59

cytokines...............M13, M94, M117, 21, T100, T105, W61, W107, W135, W204

Cytoprotection...............M143

cytoskeleton...............T57

D

D-amino acid oxidase...............W199

D-serine...............M214

D2 receptor...............M169, W107, W151, W166, 53

Data sharing...............15

Data transparency...............15

DBS...............T46, W9, 56, 59

de novo...............M37

de novo mutation...............M174, M201, W33

Decision Making...............M131, M202, M215, T13, T51, T217

declarative memory...............M7

deep brain stimulation...............M38, M90, W100, W209

default mode network...............M60, M141, T101, W11, W101

default network...............T180

delay discounting...............13

delta9-tetrahydrocannabinol...............W225

Delusions...............T192

Dementia...............T145

dendrites...............M196, W181

Dendritic Spine...............1, M161, M233, T102

dentate gyrus...............T19

depot...............M153

Depression...............4, M15, M57, M60, M61, M69, M72, M75, M84, M87, M91, M96, M98, M102, M113, M118, M121, M140, T10, T56, T63, T68, T70, T73, T77, T86, T91, T92, T97, T99, T101, T184 38, 40, W58, W63, W64, W65, W70, W74, W76, W80, W87, W90, W91, W97, W98, W107, W110, W123, 52, 56, 59

depressive disorders...............M85

Design...............8

development...............T4, T131, T202, T234, 38

Developmental...............T181, W20

Developmental Psychopathology...............M45, 20

developmental trajectories...............M34, 24

Dextromethorphan/Quinidine...............M145, T145

diabetes...............T139

diagnostic criteria...............51

diagnostic specificity...............W158

Dietary supplement...............T116

diffusion...............M106

Diffusion tensor imaging...............T32, W194

Diffusion Weighted Imaging...............M60, T205, T219

Digital Health Feedback System...............M200

dimensions of psychosis...............W192

diphtheria toxin...............W187

Direct pathway...............M137

DISC1...............M228, W149, W193

Disease prevalence...............M143

disease progression...............M139

disparities...............M2

disruptive mood dysregulation disorder...............T29

divergent transcription...............T188

DKI...............M106

DLPFC...............M196, T144, W165

DNA Methylation...............M197, W213

DNA sequencing...............T163

domesticate...............W146

Dopamine...............M28, M79, M165, M168, M176, M177, M178, M179, T192, M198, M212, M215, M217, M218, M226, M238, M248, M262, T31, T73, T135, T180, T207, T212, T227, T254, T258, W45, W69, W98, W106, W115, W171, W174, W181, W212, W217, W218, W257, W261, W262, 53

Dopamine (D2, D3) receptors...............M159, M175, M176, M177, M216, T239, W244, W247

dopamine 2 receptor...............W170

Dopamine 3 receptor imaging...............W128

dopamine d4...............W203

dopamine transporter...............M232, T31, W73, W123, 57

Dopaminergic system...............T67, W58

Dopmaine...............T136

Dopmaine Receptors...............M48

dorsal caudate...............T150, W177

Dorsal striatum...............M137, M248, W69

dorsolateral prefrontal cortex...............M42, M152, W84, W122

dorsolateral striatum...............M211

Dose-response Analyses...............M55

Down Syndrome...............W140

downregulation...............W227

DRD2 locus...............T174, W151

DREADD...............M42, T218, T233, W15, W49

DREADD Receptor...............T214

DREADDs...............M23, T235

drinking...............W215

drug abuse...............T252

Drug Discovery - new approaches...............50

drug discrimination...............M250

DTI...............M40, T176, W119

duloxetine...............W86

Dup7...............W28

Dynorphin...............T218

E

Early intervention...............6, W149

Early life stress...............M32, M39, M87, T39, T110, T139, W69

Early Phase Drug Development...............W253

early psychosis...............W206

early sensory signal processing...............T24

early signs...............45

Eating disorder...............5

Eating Disorders...............M47, T48, W46, 36

ecological momentary assessment...............M258

ECT...............W76, W103

Editorial...............8

education...............T133

EEAT2...............T64

EEG...............M121, M164, M184, T155, W103, W193, W208

EEG biomarkers...............T146, T230, W68

Effort...............W157

Electroconvulsive therapy...............M38, M68, T77, T107, T203, W55, W68, W90, W112

electroencephalography...............M160

Electronic cigarette (e-cigarette)...............M242

electrophysiology...............M131, M169, M186, T43, T88, T130, T142, T255, 37, W83

emergence...............M121

emotion...............T86

Emotion Modulation...............T7

Emotion Perception...............W12

Emotion processing...............M66, M78, T12, T71, T228, W116

emotion regulation...............M32, T12, T164

emotional response inhibition...............M152, T71

Emotional stress...............M57

Emotional Test Battery...............M72

endocannabinoid...............M15, T110

Endocannabinoids...............W94, W147

Endomicroscopy...............W211

endophenotype...............T25, M112, M171, 13, T36, T84, 39

endophenotypes...............T45, T96, T108

endurance training...............M166

energy homeostasis...............M49

epidemiology...............M45, T5, T231

Epigenetic...............3, 11, T144, W52, W243, 49

Epigenetics...............M9, M35, M39, M214, T60, T64, T165, T201, W41, W96, W140, W213, W254

epilepsy...............M142, M144

episodic memory...............41, W197, W207

ErbB4...............W160

ERP...............2, M184, T156, T230, W198

ERPs...............M160, W117

Escitalopram...............M21, T80

Esketamine...............M62, T91, T93, T106, W57

eSource...............W150

Estradiol...............M3, M4, M113, T118

estrogen...............T66

estrogen receptor...............T11

ethanol...............M251, W31

ethics...............35

evoked response potential...............M173

Excitabilty...............M243, W102

executive function...............M67, M90, M135, M224, T2

exercise...............W133, W246

exome...............W148

exome sequencing...............M37

Exposure therapy...............M10, M18

extended reward network...............W134

Extinction learning...............M245, 6

Extinction memory recall...............W118

extracellular matrix...............T251

extrastriatal dopamine D2/3 receptors...............W152

F

FAAH...............T256, W14

FAAH inhibitor...............T256

face perception...............M173

face specific processing...............M173

factor analysis...............W99

familial risk...............T5

familiarity...............T193

Fast-acting Antidepressant...............M111, T65, T70, W58, W96

fatty acids...............27, M118

fear...............T14, W146

Fear conditioning...............M6, M13, M20, M138, T6, T22, T172, W5, W13, W17, W20

Fear extinction...............M138, T6, T19, T22, W7, W9, W13, W17

fear generalization...............10, 41

fear processing...............41

FEAST...............W103

Feedback negativity...............T156

Female...............M57

Field trial...............M101

first episode schizophrenia...............M163, T173, W184, W205

First-episode psychosis...............T205, W168, W177, W197

first-episode schizophrenia...............T149, T155

FKBP5...............M39, W74

flibanserin...............T208

Fluorescence-activated cell sorting...............T182

fMRI...............2, M1, M3, M91, M98, M122, M132, M173, M224, M226, M246, M249, 17, T7, T17, T59, T117, T121, T125, T127, T128, T137, T172, T173, T257, W26, W37, W38, W47, W65, W102, W116, W118, W120, W137, W144, W157, W165, W235, W248

fMRI faces paradigm...............T52

fMRI Functional Connectivity...............M19, M80, M95, T180, W133, W222

fMRI resting state...............M163, W10, W76

fMRI, anxiety, threat...............W23

fMRI/imaging genetics...............19, T159, W1, W34, W218

FMRP...............T167

fNIR...............2, W232

Food Addiction...............W46, W244

forced swim test...............T97, W97

Fractional-anisotropy...............M106, T219, T240

fronto-striatal networks...............W151

Functional Capacity...............M170, T139

Functional connectivity...............T69, T216, W179

functional impairment...............W88

functional magnetic resonance imaging...............T66, W180, W207

functional neuroimaging...............M7, M203, 21, T166, W106, W216

functional outcome...............W189

Functional Selectivity...............M165, M176, M261, W170

Funding...............M124

FXR1P...............M66

G

g protein signaling...............M261, 27

G-protein...............W66

GABA...............M74, M84, M178, T247

GABAA...............T78, W149, W173

GABAB...............M259

GABAergic cells...............W187

GABAergic circuitry...............W155

GABAergic interneurons...............M31, T153, W183, W262

Gabapentin...............W53

GAD65/67 mRNA...............M48

gait...............T25

Galanin...............W258

gamma oscillation...............T155, W185, W186

gender...............M148, T90, T243, W38

Gene environment interaction...............M228

gene expression...............11, T8, T10, T178, T182, T229, 42, W48, W70, W84, W143, W239, 49

generalized anxiety disorder...............W12

genes...............48

genetic...............M43, M183, 13, W79, W115

genetic mouse model...............7, T25, T57, T229, 32, W239

genetics...............M120, M130, M171, M174, M219, M259, 25, T127, T132, T157, 39, W78, W111, 48

Gene–environment interaction...............T48, W207

genome editing...............M229

Genomics...............M123, 34

geography and drug addiction...............T236

Geometry...............T148

Global Deterioation Scale...............T1

Global outreach...............26

GLT-1...............M243, T253, W220

glucocorticoid...............M94, T246

glucocorticoid receptor...............M255, W74, W97

Glutamate...............M16, M30, M51, M86, M125, M175, M178, M222, M262, T64, T104, T127, T161, T178, T206, T207, T213, W96, W177, W220, W249, 29

glutamate GABA...............M198, T43, T177, W44

glutamate receptor activity...............M197

glutamate transport...............T198

glutamate/glutamine cycle...............M30

glutamatergic synapses...............W204

glutamatergic transmission...............W8

Glutamine...............M30

glutathione...............M22

glycogen synthase kinase-3...............W95

glycosylation...............M207

Glymphatic pathway...............16

Gonadal Hormones...............M105, T118, 36

GPCR...............M79, 50

GPHN...............W14

Graph theory...............T99, W68

GSK3...............M66

guanfacine...............M97

guanylyl cyclase...............M205

Gut Microbiome...............T40, T63, W126, W141

GWAS...............M93, M181, 13, 22, W21, W78

gyrification...............W28

H

habit...............M248, 22, T213

hallucinogen...............W124, W178, 52

haloperidol...............T178

harm avoidance...............M8, T47

Harm reduction...............W259

hbA1c...............T139

HDAC...............T179

HDAC inhibitors...............W41

head-to-head clinical trial...............T187, W154

health-related quality of life...............T187, W154

healthy individuals...............W122

Heart Rate Variability...............M80, T15, T262

Heroin...............M254

heterogeneity...............W99

heterogenity...............W77

high fat diet...............33

high risk...............12

high risk psychosis...............M27, W182, W189

Hippocampal Function...............W1

Hippocampus...............M11, M64, M182, T19, T57, T109, T110, T148, T178, T225, T235, T241, W107, W145, W211

hIPSCs...............32

Histamine...............W30

Histone...............T144, W96, W140

Histone methylation...............W237

HIV...............M75, T138

HIV-1...............W73

HMGB1...............M64

Hoarding Disorder...............W24

homer...............W249

Hostility...............M187

Hot Flashes...............M113

HPA axis...............M10, M39, M210, T224, W31

Hsp90...............W74

HTR3B...............W14

hub analysis...............T122

Human Factors Testing...............M200

human laboratory...............M216, M239, T222

Human Neuroimaging...............M50, M134, M216, M236, M254, 17, 19, T18, T89, T138, T143, T244, W18, W21, W23, W124, 44, 47, 51

humans...............T8, T72

hunger...............M49

Huntington's Disease...............W139

hypersexual disorder...............M210

Hypothalamic development...............M126

Hypothalamic-Pituitary-Adrenal axis...............T21, T23, T84

hypothalamus...............M105, T16

Hypoxia...............T236

I

ibudilast...............W253

imaging...............M249, M257, T142, T227

imaging genetics...............T26, W42

Immune...............M183, M188

immune mechanisms...............33, W153

impulsiveness...............T89

impulsivity...............M46, M51, M52, M53, M99, 13, T31, T53, T239, W49, W209, W245, 44

in vitro cellular model...............T167

In vivo Imaging...............1

inbred mouse strains...............T124

Incentive motivation...............M218, W258

incentive salience...............W251

inclusion and exclusion...............W216

incubation...............W240

individual differences...............M135, M252, T6, T125, W25, W126, W210, W251

Induced pluripotent stem cells (iPSCs)...............T119, T167, W48, W130, 48

infant...............M25, W25

infertility...............W16

inflammation...............M13, M64, M118, M120, M133, 21, T105, T160, 27, W89, W106

Inflammatory Markers...............M54, W61

informatics...............T75

infralimbic cortex...............T73, T213, W245

Inhibition...............T61, W145

Inhibitory control...............M260, T216, W50

inhibitory synaptic transmission...............W183

innovative methods...............W169

Insula...............T215, T243, W47, W179, W241

Insula Connectivity...............W85

Insulin...............M177, W8

insulin resistance...............M85, T83

Insulin-like growth factor 1...............T37

intellectual disability...............W27

Intelligence Quotient...............W119

interleaved TMS/fMRI...............W102

Interleukin-6...............M13

internal capsule...............W136

international...............W129

internet...............M52, M100, W24

interneuron...............T177

Interoception...............T14, T121, W47

interpeduncular...............W252

interpretation bias...............T29

intracranial self-stimulation...............T183, T208, W108

Intranasal...............T93

Intranasal formulation...............T106

intravenous administration...............W224

ion channel...............M157

iPSC...............T126

Irritability...............M107, T29, T59

ITI-007...............W174

IV Alcohol...............T262

K

Kalirin...............1, M161

kappa agonist...............M129

kappa opioid receptor...............M104, M256, T247, W50, W62, W75, W255

KCa2 channels...............M245, W257

Ketamine...............M18, M61, M62, M73, M77, M160, M208, 22, T74, T91, T94, W78, W95, W108, W113, W114

kinases...............T65

Kynurenic acid...............T128, T131, 29

kynurenine...............T4, W195

L

Lactate...............W113

Large Scale Networks...............T34, W34, 56

Laser Capture...............W200

Late-life Depression...............T87, T113, T117

Lateral Habenula...............M79, T55, T73, W94, 59

Lateral Septum...............T235

Learning...............T136

learning and memory...............T49, T128, W107, W254

Leptin...............T20

lesion...............W144

leukocyte telomere length...............M85

levetiracetam...............W3

life stress...............M75

Linkage...............M118

lipid rafts...............W66

lipids...............M118

liquid chromatography/mass spectrometry...............M74

Lisdexamfetamine...............M46, M47

Lithium...............M143, W71

Lithium response...............M82

Locus coeruelus...............M33, W117

Locus coeruleus...............M209

long noncoding RNA...............M20, T52, W213

Long Term Potentiation...............T247

long-acting-antipsychotic...............T195

longitudinal...............M50, T234

LPS...............W81

LSD1...............W237

lurasidone...............M55, T92, W172, W203

Luzindole...............T109

M

Machine learning...............M108, T96, W36

MADRS...............W150

Magnetic Resonance Imaging...............W18

magnetic resonance spectroscopy...............M16, M208, T157, W44

Magnetic seizure therapy...............M68, W68

magnetization transfer...............M141

maintenance treatment...............M235, T112

Major depression...............M56, M63, M78, M80, M86, M92, 10, T58, T60, T83, T95, T98, T105, T107, T118, T121, W55, W72, W93, 46, 58

major depression history...............T103

major depression, post-traumatic stress disorder...............M95, W59

Major Depressive Disorder...............M55, M58, M68, M81, M89, M100, M111, M188, T74, W91

Major Depressive Disorder (MDD)...............M71, M117, T62, T69, T82, T100, T114, W61, W86

Major Psychiatric Disorders...............M202

mania...............W63, W71, W79, W192

marijuana...............T210, T244, T248

Maronutrient...............W258

mass spectrometry...............T198

Maternal...............M140

maternal separation...............T28

Matrix Metalloproteinase-9 (MMP-9)...............18

MCH...............M140

MDD...............M70, M88, M107, W113

MDPV...............M250

mecamylamine...............M136

Medial frontal cortex...............M31

Medial Prefrontal Cortex...............M11, M23, M33, M78, M182, M185, M2015, T99, T102, T182, T206, T255, T259, 36

Medication adherence...............W206

Medication Development...............T222

Medicinal Marijuana...............T249

mediodorsal thalamus...............W191

Medium Spiny Neuron...............M213, W228

Melatonin...............T109

memantine...............T151

Memory...............18, T3, T42, T111, T191

Memory and Learning...............M24, M214, T150, T260, W82

Memory Consolidation and Extinction...............T19

Memory Encoding and Retrieval...............M3, M119, W82

menopause...............M3, M4, M87

mental health service use...............M2

Mentoring...............M124, 26

meta-analysis...............W61, W93, W175

metabolic safety...............M156

metabolic syndrome...............T185, T201

metabolism...............T20

Metabolomics...............M128

metabotropic glutamate receptor...............M70, M123, T82, T159, T221, W173

metals...............W159

Methamphetamine...............M234, M263, T236, T239, T240, T241, W224, W249

Methionine...............T181

methods...............60

Methylphenidate...............T13, T24

mGlu2/3 receptor...............M77

mGlu5-PAM...............W4

mglur5...............W156

mGluR5 receptors...............M245

Mice...............M138, M202

microarray...............T197

Microdialysis...............M12, T207, W257, W261

microglia...............M64, 33

microglial activation...............W182

MicroRNA...............M102, T10, T124, T199

mild cognitive impairment due to AD...............M41

Mild Traumatic Brain Injury...............T140

minocycline...............T76

Minor Tobacco Alkaloids...............T237

Mismatch Negativity...............T152, T202, W198

missence mutations...............T163

Mitochondria...............T197, W185, W228

mitochondrial function...............W3

Mixed features...............T92

mobile health...............W206

Mobile phones...............M101

Mobile technology...............W105

moderators...............M253

molecular mechanisms...............M196, M209, T10, 50, 54

monkey...............M42, T252, W161

monkeys...............W244

Monoamine oxidase A...............M150, T116

monoamines...............T88, W83

Mood...............M66, T137

mood and addiction...............M246

mood and anxiety disorders...............M103, T84, W105

mood disorder...............M56, M116

mood disorders...............M109, T77, T89, T108, 30, W85

morphine...............M230, T225

morphological and resting state brain activity...............M237

motivated drug taking...............M231

motivation...............M125, M155, M238, T156, T212, W157, 21

motor stereotypies...............W33

mouse behavior...............M162, M230, W70, W196

mouse brain...............W194

mouse model...............T158, T185, T218, 45

Mouse models...............W170, W183

MPTP...............W138

MR spectroscopy...............M175, T100, T104, W163

MRI...............T25, M144, 16, T28, T41, T161

mRNA...............W252

MRS...............M22, M262, 12, W19

mTOR...............M230, W75

mu-opioid receptors...............M261, 58

multi-episode schizophrenia...............M166

Multiplex families...............T163

multivariate...............T189, W176

muscarinic acetylcholine receptor...............T65, W125, W173

myoinositol...............W19

N

N-acetylcysteine...............M241

Na+/H+ exchanger...............57

NAcore...............W257

NADPH oxidase...............M92

Naltrexone...............M254

national representative sample...............W230

national study...............W230

Native American...............W215

Native Americans...............M53

natural history genomic studies...............W169

negative emotionality...............W255

Negative Symptoms...............M155, M158, M204, W188

neural activity...............T188

neural circuitry...............23, T35, W80

neural circuits...............M119, M209, 14, 55

neural plasticity...............M189, T54

Neuregulin...............W138

Neuregulin-1...............W160

neuregulin-3...............T223

neuritogenesis...............M207

neuroactive steroid...............M74

neuroanatomy...............T36

neurobiology, stress, depression, anxiety, adolescence...............M14, M32, W96

neurochemistry...............T200

neurocircuitry...............M40, 43

neurocognition...............M189, T108, T154, T164, T175, W77, W189

neurodegeneration...............T141, W139

neurodegenerative...............T141

Neurodegenerative Disease...............M146

Neurodevelopment...............M146, M220, 34, 37, 42, W34, W130, 48

Neurodevelopmental Disorders...............T32, W149, W196

neuroeconomics...............W164

Neuroendocrine...............M63

Neuroendocrine system...............T246

neuroendocrinology...............T66

Neurofeedback...............47

Neurogenesis...............M138, T49, T109

neurogranin...............T160

Neuroimaging...............M150, T75, T96, T215, 34, W36, W55, W219, W226, 6

neuroimmune...............M117, W253

Neuroimmunology...............W204

Neuroinflammation...............M89, M110, M188, 12, T76, 40, T205, W81, W107

Neurological disorder...............M143

Neuromodulation...............T191, W121

Neuronal Epigenome...............W52

neurons...............T126, W181

neuropeptide Y...............M73

Neuropeptides...............W59

neurophysiological aspects of the origin of consciousness,...............T134

Neuropil...............W188

Neuroplasticity...............20, T211, W52, W210

Neuropsychiatric Adverse Events...............M244

neuropsychiatric inventory...............M145

neuropsychology...............T186, T196, T260

Neuroreceptor imaging...............T143, W45

neurosurgery...............W18

Neurotechnology...............W128

neuroticism...............M236

neurotransmitter co-release...............M125

new targets...............W90

nicotine...............M97, M136, M235, T129, T220, T243, T255, T257, W211, W235, W252

nicotine addiction...............T237, W238

Nicotine dependence...............M244, M249, T223, T248, W221

nicotinic acetylcholine receptors...............M97, M136, M162, T212, T248, W238

NIH...............8

nitric oxide...............T214, T251

nitric oxide donor...............M205

NMDA...............W199

NMDA Antagonists...............M18, M160, T49

NMDA channel blocker...............M212

NMDA glycine-site receptor...............M158, W245

NMDA Receptor...............1, M62, M186, M212, T153, W2, W185, W196, 29

NMDA Receptors...............T183, W167

non pharmacological interventions...............M100, 23, W205

non-linear...............M121

Non-Pharmacological Therapy...............M1, 45

Nonhuman Primate Models...............M75, T261

Nonhuman Primates...............M256, T237, W10, 56

norepinephrine...............T11

not just right experience...............M8

Notch...............M126

novel object recognition...............M214, W203

novel therapeutics...............T169, W70

NPSR1...............M16

Nucleus Accumbens...............M211, M213, T94, T214, T242, T253, W8, W13, W62, W84, W228, W234, 54

Nucleus Accumbens Shell...............T213, W236, W257

Nutrigenomics...............T48

O

Obesity...............T50, T58, T137, T246, 28, W8, W45, W46, W133, W134, W226

Obsessive Compulsive Disorder...............M22, 22, T125, T142, T143, W11, W18, W19, W29

Obsessive-Compulsive and Related Disorders...............M21

occupancy...............W152

OCD...............7, M8, M18, M22, T22, W9, 56

odor-related trauma...............M17

older adults...............M2

older patients...............W172

Olfaction...............M36

olfactory...............M17, M192

Omega-3 Fatty Acid...............M69, M82

open science...............W169

opioid...............M257, T228

Opioid dependence...............T217, W232

Opioid system...............4, T224

opioids...............M238, M258

OPRM1 A118G...............T224

optogenetics...............7, M76, M119, M137, M218, T19, T55, T158, T233, T259, W62, W117

Orbitofrontal cortex...............T238, W9

orexin...............W15

organic cation transporters...............T61, 57

oscillation...............M33

ovarian steriods...............M116

oxidative stress...............M22, M67, M194, T39

OXTR...............W146

oxytocin...............M122, M132, 24, T190, T226, T242, 27, W146, W164, W261

P

P300...............W193

p38 MAPK...............W50, W75

P50...............M25

PACAP...............T20, T115, T120, W59

Pain...............M142, M238

pair bond...............W131

Palatable food...............T49

paliperidone...............T195

paliperidone palmitate...............T187, W154

panic...............T14, W15

panic attacks...............M16

PANSS...............T204, W150

Parkinson's disease...............W138

Parkinsonism...............57

parvalbumin...............M31, T160, T197, W183, 53

parvalbumin interneurons...............M157, M169, T158, T199, W155, W234

pathological gambling...............M223

pathophysiology...............M178, M194, 30

Pavlovian...............M218

Pavlovian conditioning...............M242, W251

PDE2...............M92

PDE4...............M184, M228

pediatric...............T22, W32

penetrance...............W32

Perimenopause...............M113

perinatal...............W229

perinatal anxiety...............T103

perinatal depression...............T103

Peripheral Nerve Stimulation...............W121

personality...............W99, W122

PET...............2, M58, M70, M123, M144, M151, W156, M159, M226, T135, T150, T180, W174

PET Imaging...............M146, T140, W42, W123

PET study...............M227, 40

PFC...............W173

Pharmacodynamics...............W137

pharmacogenetic...............W15

Pharmacogenetics...............M59, M220, T127, T174, 60

Pharmacogenomics...............M195, W86, W87, W168, 48

Pharmacokinetics...............M34, T232

Pharmacology...............T56, T132, T169, 50

Pharmacotherapy...............M21, M239

phase of illness...............T193

phencyclideine...............W203

Phenotype Screening...............41

Phenotypes...............M201, W255

Phosphodiesterase-4 (PDE4)...............T42

Physical dependence...............M129

physical exercise...............M189

PKMzeta...............M225

Placebo Response...............W86

placebo-controlled trial...............M81

Polygenetic Risk Score...............M183, W1

polymorphism...............T124

POMC...............M126

population -based...............T194

positive allosteric modulators...............T206, W125

Positron Emission Tomography...............M54, M134, M216, T107, T143, T221, T248, W10, W60, W182

postmortem...............T198

Postmortem Brain Tissue...............M147, M196, M197, T43, T179, W42, W153, W200

postmortem human brain...............M207, W69

postpartum...............M140

Postpartum depression...............M74, T116, T66

posttraumatic stress...............M7, T23

Posttraumatic stress disorder...............M15, M26, M61, T12, T18, W88, 47

poverty...............M40

prairie voles...............W131

Precision Medicine for Depression...............M108

Preclinical...............M129

Preclinical Trial Methodology...............T1

precuneus...............T35

prediction...............19

Predictive Models...............T166, W189

Prefrntal cortex...............W149

prefrontal circuit...............W65

Prefrontal cortex...............M28, M96, M102, M162, M164, M165, M202, M221, T24, T28, T188, T207, T215, W2, W60, W217

prefrontal-amygdala-connectivity...............M32

Pregabalin...............W53

pregnancy...............M25, M74, T79, T232

prelimbic...............W214

premenstrual dysphoric disorder...............M116, T78

prenatal...............M44

prenatal smoking...............W29

prenatal stress...............M31, T40, 33

Prepulse Inhibition...............W187

Prescription drug abuse...............W230

prevalence...............W24

Prevention...............M112, T116, 45

Prevention of Alzheimer's disease...............M43, T1

primate model...............W22

probabilistic reasoning...............T192

Probabilistic reinforcement...............W161

Progesterone...............M113, T66, W246

propanolol...............T9

protein aggregation...............T184

Proteomics...............W200

proteostasis...............T184

Pseudobulbar affect...............T145

Psychiatric Comorbidity...............M103, M148

psychiatric disorders...............M194

psychiatric genetics...............M181, M229

psychiatry...............W136

psychoeducation...............W40

Psychoneuroimmunology...............M75, T100, W135

psychophysiology...............T15, T78

psychosis...............M174, M203, M212, T166, T186, T190, T204, W40, W162, W191

psychosis continuum...............W159

psychosis risk...............37

psychosocial stress...............W135

psychosomatic medicine...............W135

Psychostimulant...............T221, W261

Psychotherapy...............M9, M10, T12

psychotic disorders...............30

PTSD...............M6, M10, M17, M19, M23, M138, T8, T10, T15, 41, W17, W21, W23, W53, W74, W120, W147

pyramidal neuron...............M185

Q

QTG...............M229

QTL...............M219, M229

Quantitative Electroencephalography (qEEG)...............T209

R

R-fmri...............W63

Rabies tracing...............M217

Radiotracer...............M146

raloxifene...............M152

Raman spectroscopy...............T126

Randomised clinical trial...............M47

randomized clinical trial...............M100, W184

raphe...............T55

Rapid Antidepressant...............W57

rare variation...............W33, W201

Rat...............M46, M102, M129, T68, T238

rat strains...............M136

Rating scales...............W129

Reapprasial Training...............M149

reasons for change...............W215

recollection...............T193

Recovery...............W227

Recurrence risk...............W56

Redox modulation...............T39, 29

Regeneration...............W123

reinforcement...............T31

Reinforcement learning...............M155, T89, W161, W262

reinstatement...............M243, T235, W231

rejection...............W216

relapse...............M235, M240, M252, W214, W248

Relapse Prevention...............M21, T170, T195

relatives...............M199

Religion...............M127

repetitive behavior...............7

repetitive transcranial magnetic stimulation...............T112, 47

Replication...............8

Reproducibility...............8

reproduction...............T20

Research domain criteria (RDoC)...............M5, M7, M109, W158

Resilience...............M11, M87, M209, W52, W145

Resting state...............T18, T216

resting state fMRI...............T34, T69

Resting State Functional Connectivity...............M5, M14, M135, M236, T26, T36, T99, T101, T125, T149, T234, T239, T240, T243, W44, W85, W90, W101, W192, W197, W202, W209, W222, W235, W244, 46

Rett Syndrome...............T37

reversal learning...............T257

Reward...............M122, M254, M260, T47, T50, T94, T171, T238, W108, W161, W250, W251

reward neural circuitry...............M105, T46, W37, W90

reward pathwayd...............M238

reward prediction error...............W13, W262

reward processing...............M223, 21, T246, 36, 44

reward system...............M132, T33

Reward-based decision-making...............T257, W79, W157

RhoA...............T225

RiboTag...............W228

riluzole...............M86, M243

Risk...............M87, M131, T194, T217

risk taking behaviors...............M252

RNA binding protein...............M229

RNA Sequencing...............M116, T57, T127, W30, W42

RNA splicing...............T178

RNA-seq...............M96, T54, W10

ROC analysis...............M145

rTMS...............M30

S

S-glutathionylation...............M133

safety...............W172

Salience...............W117

salience network...............T18, W11, W222

Satiety...............M72

Schizophrenia...............1, M27, M147, M152, M153, M154, M156, M157, M158, M159, M161, M164, M167, M170, M171, M172, M173, M174, M179, M180, M181, M183, M188, M189, M191, M192, M193, M195, M197, M198, M199, M201, M204, M205, M206, M208, M235, T131, T151, T152, T153, T154, T156, T157, T158, T159, T160, T161, T162, T163, T164, T168, T169, T170, T171, T172, T177, T179, T181, T183, T184, T188, T189, T193, T194, T195, T196, T197, T199, T200, T202, T203, T204, 32, 39, 42, W152, W153, W156, W159, W160, W161, W162, W163, W164, W165, W169, W171, W172, W174, W176, W179, W180, W182, W186, W194, W195, W196, W204, 29, 50, 53

schizophrenia genetics...............M183, T192, W167, W175, W201

schizophrenia prodrome...............M163, W190, W198

Schizophrenia, Dopamine, Antipsychotics...............M151, M165, M168, M169, W166

schizophrenia, moderators...............T175

Schizophrenia-like Behavior...............M184, W170

schizotypy...............W167

Scopolamine...............T65, W58, W64

Scoring Accuracy...............W150

screening...............W199

seasonal affective disorder...............W60

selective estrogen receptor modulator...............M152

Self-Administration...............M221, M231, M234, M240, T237, T242, T261, W225, W231, 54

self-injury...............M38

Sensitive Period...............20, W35

sensitization...............T221, T255, W250

sensorimotor...............T45

sensory gating...............M184

sensory processing...............M8

septum...............M79

sequencing...............25, W148

Serious Mental Illness...............M200, W132

Serotonin...............M73, M77, M79, T72, 33, W5, W81, W116, W127, W178, W242

Serotonin 1b receptor...............M58, T53

serotonin 2A...............T182, T252

Serotonin 5-HT2C Receptor...............M134, W175

Serotonin 5-HT7...............W236

serotonin reuptake inhibitors...............T107

Serotonin Transporter...............M12, M60, T229, W60, W123

SERT...............W166

sex difference...............M69, M97, M109, 9, 34, W6, W241

Sex differences...............M12, M80, M251, T3, T6, T33, T60, W98, W118, W134, W219, W246

Sexual Dimorphism...............9, T98

sexual dysfunction...............T114

Sheehan Suicidality Tracking Scale...............M127

short-acting Kappa opioid receptor antagonist...............M104

sibling...............T194, W77

sign-tracking...............W126

Skin conductance response...............W118

skull shape...............W28

SLC6A4...............W14

sleep...............M114, M139, T34, T44, T128, T209, W110, W208

sleep disturbance...............M226, W16

sleep spindles...............T158, T191

Slitrk5...............22

slow waves...............T44

smartphone...............W206

Smoking...............M259, T210, W156, W229

Smoking Cessation...............T227, M244

Smoking urge...............M242, T226

SNP...............W167

sociability...............M36

Social...............T148, W247

Social Anxiety...............T7, W12

Social buffering...............W80

social cognition...............M203, M254, 24, T154, 36

Social Competence...............T176

Social defeat stress...............M33, M57, M61, M230, T81, T118, T233, W59, W80, W108

Social Functioning...............T111

social interaction...............T115, W216

social neuroscience...............M40, M122, T146

social recognition memory...............T190, T193

Social Rhythms...............M115

Social stimuli...............T228

social stress...............38, W38

social subordination...............W244

Source Localization...............M164

SPECT...............W152

Spice/K2 cannabinoids...............T250

spines...............T225

SSRI...............M186, T69, T80, T97, W93

startle latency...............M171

statistical methods...............T231, W111

stereotypy...............M38

stimulant...............T9

Stimulant Abuse...............W249

Stress...............M63, M64, M76, M94, M102, M249, T110, T120, W6, W22, W52, W94, W98, W214, 49

Stress circuits...............T67

stress response circuitry...............M109, 10

striatum...............M27, M262, T33, T69, T135, W63

Stroke...............T145

structural covariance...............T26

Structural MRI...............M24, M40, M181, M190, T41, T173, T189, 37

Subcallosal Cingulate...............W76, 59

Subclinical psychosis...............T41, T176, W190

subgenual...............T86, T99

Subjective Cognitive Impairment...............T1

subjective effects...............T129, T220, W224

Substance abuse...............M232, 17, T183

Substance use...............W154

substance use disorder...............5

Substance-related disorders...............T50, W233

subthalamic nucleus...............W209

Subtypes...............46

Suicide...............M83, M127, T5, T52, T56, W65, W69, W84

Suicide Assessment...............T27, W57

suicide behavior severity...............M93

sunshine act...............35

sustained attention...............T24

SV2A protein...............W3

synapses...............T43

synaptic connctions...............W155

Synaptic Plasticity...............M137, M245, 18, T223, T251, 28, W4, W143, W234, W250, 49

synaptic spine...............M205

Synthesis...............T72

systemic inflammation...............M110, W109, W135

systems biology...............3, 34

T

targeted cognitive training...............M180

task-based functional connectivity...............M17

tau...............T141

Technology...............M115

telemetry...............W208

Telomere...............W233

temperament...............W99

Test Retest...............M72

testosterone...............T11

Thalamus...............T74, W188

THC...............W7, W259

threat...............T17

Threat Conditioning...............W53

Threat of Shock...............T9, W23

thyroid...............T103

tianeptine...............58

timing...............W178

TMS...............M164, W102

Tobacco Smoking...............M247

Tolerability...............M193

Tolerance...............W221

Tourette syndrome...............7, T143, W29

toxoplasmosis...............M44

trace amine-associated receptor 1...............W231

Tractography...............M60, M106, W100, 59

Training...............M124, 26, T133

Trajectories...............W36

transcranial current stimulation...............T191

Transcranial Magnetic Stimulation...............T27, T107, T168, T211, W112, W260

transcription...............W183

transcription factor...............T165, W243

transcription factors...............10, W143

Transcriptomics...............3, T54, W143

transgenerational...............T40

transgenic mice...............M76, M185

TRANSGLUTAMINASE 2...............M84

translational imaging...............W260

Translational Neuroscience...............M135, T133

Transporters...............M130

Trauma exposure...............6, M5, W53, W109, W118, W120

trauma history...............T103

Traumatic Brain Injury...............T145

Traumatic stress...............M246

Treatment...............M224, M241, T217, 46, W78, W246

Treatment Outcome Prediction...............M78, M237, T1, T254

treatment refractory...............T82

Treatment resistance...............T203, W162

Treatment Resistant Depression...............M65, M103, T80, T85, T93, T97, T106, W100, W112, W114

treatment response...............M195, 27, W168, W175

TrkB...............M233, T102

trust...............W164

Tryptophan...............W141, W195

Tryptophan depletion...............T72

TSPO...............T140

TSPO and [11C]PBR-28 PET...............M89, M227, 12, W182

twins...............T200

type 2 diabetes mellitus...............M141, T83, W109

Type-2 Diabetes...............W46

U

UCSD Performance-Based Skills Assessment (UPSA)...............M71

ultra high-risk youth...............M163

Unconditioned responses...............W120

upregulation...............W227

uptake 2...............T61

User-centered design...............M101, T133

V

Vagus Nerve Stimulation...............W121

Varenicline...............M235, M253, T257

ventral hippocampus...............M19, M96, T16, T81

Ventral Striatum...............M182

Ventral Tegmental Area...............M209

Ventral tegmental area (VTA)...............M125, M217, M218, M230, T55, T247, W217, W262

ventrolateral prefrontal cortex...............T104, W38

Verbal Memory...............W82

vesicular glutamate transporter (VGLUT)...............M125

violence...............T149

Virtual Reality...............W157

vmPFC...............W238

voltammetry...............M232, M256, W58, W127

Vortioxetine...............M71, W83

voxel-based morphometry (VBM)...............T189, W18, W176

VTA...............W80

Vulnerability...............M231, 9, T21

W

wakefulness...............W208

wheel running...............W73

White Matter...............M106, M191, W194, W195

Whole exome sequencing...............M53, M116, W33, W201

williams syndrome...............W28

Withdrawal...............M249, M252, M257, T256, W31

women...............W219, W224

Women's Mental Health...............T79, W109

work readiness...............T187

working memory...............M42, M135, M198, M221, T165, T180, W2, W180, W187, W207

Working Memory Capacity...............T9

working memory fMRI...............W151, W171

X

xCT...............W220

Y

Yoga...............M1, T162

Z

zebrafish...............T132

ziprasidone...............M103

ΔFosB...............T81